Your cart is empty.
Männedorf, Switzerland, March 25, 2014 - The Tecan Group (SIX Swiss Exchange: TECN) today announced the publication of its 2013 Annual Report in the Investor Relations section of the company's website at www.tecan.com. An iPad App for the Tecan Financial Reports is available from the App Store. Tecan already published its 2013 financial results in a press release and at the Press Briefing on Annual Results and Analysts' Conference held on March 11, 2014.
Today also saw the publication and dispatch of the notice of the Annual General Meeting of the Tecan Group AG. The Annual General Meeting will take place on April 14, 2014. The notice is also published on the company's website.
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2013, Tecan generated sales of CHF 388 million (USD 419 million; EUR 316 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
For further information:
Head of Corporate Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89